The National Institutes of Health鈥檚 Researching COVID to Enhance Recovery (RECOVER) Initiative opened enrollment for clinical trials to evaluate the safety and effectiveness of at least four potential treatments for Long COVID in adults. The project expects to launch trials to test at least seven more treatments in coming months, informed by findings from its other research over the past two years.

鈥淩ecognizing that more than one solution is likely needed, we鈥檝e taken the lessons learned from RECOVER participants to design rigorous clinical trial platforms that will identify treatments for persons with different symptom clusters to improve their function and well-being,鈥  Walter Koroshetz, M.D., director of the NIH鈥檚 National Institute of Neurological Disorders and Stroke.

In related news, the Department of Health and Human Services today officially  its Office of Long COVID Research and Practice to coordinate and lead the federal response to Long COVID.
 

Related News Articles

Headline
A study published April 8 by the Public Library of Science鈥檚 Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of鈥
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.鈥檚 nomination for secretary of the Department of Health and Human Services. A鈥
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu鈥
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers鈥
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability鈥
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the鈥